Results 91 to 100 of about 249 (106)
Abstract Dotinurad has been approved in Japan as a selective urate reabsorption inhibitor for the treatment of gout and hyperuricemia. The relationship between uric acid crystallization and the use of uricosuric drugs is widely acknowledged; however, the relationship between changes in urinary uric acid concentration and urine pH or volume has not been
Toshinari Takahashi
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Ideal Pharmacokinetic Profile of Dotinurad as a Selective Urate Reabsorption Inhibitor
Drug Metabolism and Pharmacokinetics, 2020Junichiro Uda +2 more
exaly

